HEAL WELL. AGE WELL. LIVE LONGER.(800) 266-7207   ·   contact@clearhealthpass.com
Federal record

On the record.
In writing.

Selected milestones from the company’s reported CMS and FDA engagement. Read the date, the action and what it establishes.

Company-reported history. Participation, correspondence and receipt do not establish agency endorsement, product approval or reimbursement. No formal tribal consultation is claimed.
Oct 28, 2026 / Sovereignty

Strengthen, not diminish

The Tribes behind Rampart™ DL Matrix call for Government-to-Government consultation on Medicare skin-substitute policy.

Read the release↗
Jul 9, 2026 / Rulemaking

Written FDA docket comments

Comments to FDA-2025-N-6895; supplemental comments followed on July 23.

Explore the context↗
Jan 17, 2026 / Clinical evidence

Government-to-government receipt

CHP reports receipt confirmation for its post-market evidence submission.

Explore the context↗
Dec 15, 2025 / Sovereignty

Q4347 company listed as “Tribal”

A historical CMS pricing-list entry.

Explore the context↗
Nov 1, 2025 / Clinical evidence

Post-market evidence submitted

Materials report submission to CMS and all seven Medicare Administrative Contractors.

Explore the context↗
Sep 16, 2025 / Rulemaking

Sovereign submission posted

The Physician Fee Schedule submission was posted on Regulations.gov.

Jul 16, 2025 / Rulemaking

910-page PFS comment

Company-reported comment on the CY 2026 Physician Fee Schedule proposed rule.

May 22, 2025 / CMS engagement

Meeting hosted by the Division of Tribal Affairs

Described as a meeting, not a formal tribal consultation.